APA (7th ed.) Citation

Xu, C., Tang, Z., Wei, M., Liu, D., Pang, Q., Huang, B., . . . Wu, F. (2025). Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: A novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Xu, Cheng, Zhihong Tang, Meng Wei, Danxi Liu, Qingqing Pang, Baishan Huang, Xinglin Mo, Feixiang Wu, and Feixiang Wu. Predicting Recurrence and Recurrence-free Survival in Initially Unresectable Hepatocellular Carcinoma: A Novel Nomogram for Patients Undergoing Conversion Hepatectomy with Lenvatinib, PD-1 Inhibitor, and Interventional Therapy. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Xu, Cheng, et al. Predicting Recurrence and Recurrence-free Survival in Initially Unresectable Hepatocellular Carcinoma: A Novel Nomogram for Patients Undergoing Conversion Hepatectomy with Lenvatinib, PD-1 Inhibitor, and Interventional Therapy. Frontiers Media S.A, 2025.